Role of annexin II in estrogen-induced macrophage matrix metalloproteinase-9 activity: The modulating effect of statins

Atherosclerosis

Volumn 189, Issue 1, 2006, Pages 76-82

  Hwang, Juliana ^a   Hodis, Howard N ^a   Hsiai, Tzung K ^a,b   Asatryan, Liana ^a   Sevanian, Alex ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

Annexin II; Estrogen; Macrophages; Matrix metalloproteinases; Statins

Indexed keywords

ESTRADIOL; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G ANTIBODY; LIPOCORTIN 2; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; SIMVASTATIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL MEMBRANE; CONCENTRATION RESPONSE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME REGULATION; ESTROGEN ACTIVITY; HEART INFARCTION; MACROPHAGE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANNEXIN A2; BLOTTING, WESTERN; CELLS, CULTURED; ESTRADIOL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; SIMVASTATIN;

EID: 33748965886     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.026     Document Type: Article

References (30)

1. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group. JAMA 280 (1998) 605-613
2. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 (2002) 321-333
3. Herrington D.M., Vittinghoff E., Lin F., et al. Statin therapy, cardiovascular events, and total mortality in the heart and estrogen/progestin replacement study (HERS). Circulation 105 (2002) 2962-2967
4. Zanger D., Yang B.K., Ardans J., et al. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol 36 (2000) 1797-1802
5. Newby A.C. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85 (2005) 1-31
6. Razandi M., Pedram A., Park S.T., et al. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 278 (2003) 2701-2712
7. Ohkawara M., Kuroiwa T., and Numano F. Immunohistochemical studies on annexins I and II in Takayasu arteritis. Ann NY Acad Sci 947 (2001) 390-393
8. Brownstein C., Deora A.B., Jacovina A.T., et al. Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages. Blood 103 (2004) 317-324
9. Cesarman G.M., Guevara C.A., and Hajjar K.A. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J Biol Chem 269 (1994) 21198-211203
10. Luan Z., Chase A.J., and Newby A.C. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler Thromb Vasc Biol 23 (2003) 769-775
11. Ganne F., Vasse M., Beaudeux J.L., et al. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes-a possible protective mechanism against atherothrombosis. Thromb Haemost 84 (2000) 680-688
12. Xu X.P., Meisel S.R., Ong J.M., et al. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99 (1999) 993-998
13. Falcone D.J., Borth W., Khan K.M., et al. Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II. Blood 97 (2001) 777-784
14. Gerke V., and Moss S.E. Annexins: from structure to function. Physiol Rev 82 (2002) 331-371
15. Brownstein C., Falcone D.J., Jacovina A., et al. Annexin II: a mediator of cell surface-specific plasmin generation. Ann NY Acad Sci (2001) 947
16. Shah P.K. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med 3 (1998) 199-206
17. Loftus I.M., Naylor A.R., Bell P.R., et al. Matrix metalloproteinases and atherosclerotic plaque instability. Br J Surg 89 (2002) 680-694
18. Lijnen H.R. Extracellular proteolysis in the development and progression of atherosclerosis. Biochem Soc, Trans 30 (2002) 163-167
19. Villablanca A.C., Lewis K.A., and Rutledge J.C. Time- and dose-dependent differential upregulation of three genes by 17 beta-estradiol in endothelial cells. J Appl Physiol 92 (2002) 1064-1073
20. Cipollone F., Fazia M., Lezzi A., et al. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation 107 (2003) 1479-1485
21. Porter K.E., Naik J., Turner N.A., et al. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. J Vasc Surg 36 (2002) 150-157
22. Bellosta S., Via D., Canavesi M., et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vasc Biol 18 (1998) 1671-1678
23. Fukumoto Y., Libby P., Rabkin E., et al. Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits. Circulation 103 (2001) 993-999
24. Guijarro C., Blanco-Colio L.M., Ortego M., et al. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res 83 (1998) 490-500
25. Gertz K., Laufs U., Lindauer U., et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34 (2003) 551-557
26. Nguyen M., Arkell J., and Jackson C.J. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 33 (2001) 960-970
27. Razandi M., Alton G., Pedram A., et al. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol Cell Biol 23 (2003) 1633-1646
28. Lincoln D.W., Phillips P.G., and Bove K. Estrogen-induced Ets-1 promotes capillary formation in an in vitro tumor angiogenesis model. Breast Cancer Res Treat 78 (2003) 167-178
29. Wingrove C.S., Garr E., Godsland I.F., et al. 17beta-estradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim Biophys Acta 1406 (1998) 169-174
30. Lee Y.J., Lee E.B., Kwon Y.E., et al. Effect of estrogen on the expression of matrix metalloproteinase (MMP)-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproteinase-1 in osteoarthritis chondrocytes. Rheumatol Int 23 (2003) 282-288